Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system?

Camilla Rocchi, Maria Albanese, Fabio Placidi, Andrea Romigi, Benedetta Lauretti, Girolama A. Marfia, Claudio Liguori, Maria G. Marciani, Nicola B. Mercuri, Francesca Izzi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: The link between the autonomic nervous system and restless legs syndrome (RLS) has been recently postulated. Since dopaminergic agents are used as first-line treatment for RLS, the purpose of our study is to verify whether chronic pramipexole treatment could influence the autonomic control of cardiovascular reflexes and heart rate variability (HRV) in RLS during wakefulness. Methods: Consecutive drug naive RLS patients underwent polysomnography (PSG), subjective scales, and cardiovascular function tests including head-up tilt test (HUTT), Valsalva maneuver, deep breathing, handgrip and cold face before and after 3-month pramipexole therapy. HRV analysis was performed in the frequency domain using both autoregressive and fast Fourier transform algorithms in rest supine condition and during HUTT. Results: Twenty RLS patients reported a significant reduction of RLS symptoms after pramipexole treatment, while PSG did not show significant improvements except for periodic limb movement index. Pramipexole induced a trend to a lower systolic blood pressure and a significant higher variation of systolic and diastolic blood pressure at HUTT. Cardiovascular responses to the other tests were unchanged. No significant differences in HRV spectral analysis between drug naive and treated patients were observed. Moreover, the within-group analysis of HRV between orthostatic and supine position did not show any significant change in sympathetic and parasympathetic components both in the drug naive and pramipexole groups. Conclusions: Chronic pramipexole treatment does not seem to affect autonomic balance during wakefulness. Considering that neither PSG data nor autonomic parameters are significantly modified by pramipexole, we hypothesize a non-dopaminergic autonomic dysfunction in RLS.

Original languageEnglish
Pages (from-to)1071-1076
Number of pages6
JournalSleep Medicine
Volume16
Issue number9
DOIs
Publication statusPublished - Sep 1 2015

Fingerprint

Restless Legs Syndrome
Autonomic Nervous System
Polysomnography
Heart Rate
Blood Pressure
Wakefulness
Head
Therapeutics
Pharmaceutical Preparations
Valsalva Maneuver
Dopamine Agents
Supine Position
Fourier Analysis
pramipexole
Reflex
Respiration
Extremities

Keywords

  • Autonomic nervous system
  • Cardiovascular reflexes
  • Heart rate variability
  • Pramipexole
  • Restless legs syndrome
  • Sleep

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chronic dopaminergic treatment in restless legs syndrome : Does it affect the autonomic nervous system? / Rocchi, Camilla; Albanese, Maria; Placidi, Fabio; Romigi, Andrea; Lauretti, Benedetta; Marfia, Girolama A.; Liguori, Claudio; Marciani, Maria G.; Mercuri, Nicola B.; Izzi, Francesca.

In: Sleep Medicine, Vol. 16, No. 9, 01.09.2015, p. 1071-1076.

Research output: Contribution to journalArticle

Rocchi, C, Albanese, M, Placidi, F, Romigi, A, Lauretti, B, Marfia, GA, Liguori, C, Marciani, MG, Mercuri, NB & Izzi, F 2015, 'Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system?', Sleep Medicine, vol. 16, no. 9, pp. 1071-1076. https://doi.org/10.1016/j.sleep.2015.04.016
Rocchi, Camilla ; Albanese, Maria ; Placidi, Fabio ; Romigi, Andrea ; Lauretti, Benedetta ; Marfia, Girolama A. ; Liguori, Claudio ; Marciani, Maria G. ; Mercuri, Nicola B. ; Izzi, Francesca. / Chronic dopaminergic treatment in restless legs syndrome : Does it affect the autonomic nervous system?. In: Sleep Medicine. 2015 ; Vol. 16, No. 9. pp. 1071-1076.
@article{6499b1c0131f485abc4cca5b7ce4becd,
title = "Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system?",
abstract = "Objective: The link between the autonomic nervous system and restless legs syndrome (RLS) has been recently postulated. Since dopaminergic agents are used as first-line treatment for RLS, the purpose of our study is to verify whether chronic pramipexole treatment could influence the autonomic control of cardiovascular reflexes and heart rate variability (HRV) in RLS during wakefulness. Methods: Consecutive drug naive RLS patients underwent polysomnography (PSG), subjective scales, and cardiovascular function tests including head-up tilt test (HUTT), Valsalva maneuver, deep breathing, handgrip and cold face before and after 3-month pramipexole therapy. HRV analysis was performed in the frequency domain using both autoregressive and fast Fourier transform algorithms in rest supine condition and during HUTT. Results: Twenty RLS patients reported a significant reduction of RLS symptoms after pramipexole treatment, while PSG did not show significant improvements except for periodic limb movement index. Pramipexole induced a trend to a lower systolic blood pressure and a significant higher variation of systolic and diastolic blood pressure at HUTT. Cardiovascular responses to the other tests were unchanged. No significant differences in HRV spectral analysis between drug naive and treated patients were observed. Moreover, the within-group analysis of HRV between orthostatic and supine position did not show any significant change in sympathetic and parasympathetic components both in the drug naive and pramipexole groups. Conclusions: Chronic pramipexole treatment does not seem to affect autonomic balance during wakefulness. Considering that neither PSG data nor autonomic parameters are significantly modified by pramipexole, we hypothesize a non-dopaminergic autonomic dysfunction in RLS.",
keywords = "Autonomic nervous system, Cardiovascular reflexes, Heart rate variability, Pramipexole, Restless legs syndrome, Sleep",
author = "Camilla Rocchi and Maria Albanese and Fabio Placidi and Andrea Romigi and Benedetta Lauretti and Marfia, {Girolama A.} and Claudio Liguori and Marciani, {Maria G.} and Mercuri, {Nicola B.} and Francesca Izzi",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.sleep.2015.04.016",
language = "English",
volume = "16",
pages = "1071--1076",
journal = "Sleep Medicine",
issn = "1389-9457",
publisher = "Elsevier",
number = "9",

}

TY - JOUR

T1 - Chronic dopaminergic treatment in restless legs syndrome

T2 - Does it affect the autonomic nervous system?

AU - Rocchi, Camilla

AU - Albanese, Maria

AU - Placidi, Fabio

AU - Romigi, Andrea

AU - Lauretti, Benedetta

AU - Marfia, Girolama A.

AU - Liguori, Claudio

AU - Marciani, Maria G.

AU - Mercuri, Nicola B.

AU - Izzi, Francesca

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Objective: The link between the autonomic nervous system and restless legs syndrome (RLS) has been recently postulated. Since dopaminergic agents are used as first-line treatment for RLS, the purpose of our study is to verify whether chronic pramipexole treatment could influence the autonomic control of cardiovascular reflexes and heart rate variability (HRV) in RLS during wakefulness. Methods: Consecutive drug naive RLS patients underwent polysomnography (PSG), subjective scales, and cardiovascular function tests including head-up tilt test (HUTT), Valsalva maneuver, deep breathing, handgrip and cold face before and after 3-month pramipexole therapy. HRV analysis was performed in the frequency domain using both autoregressive and fast Fourier transform algorithms in rest supine condition and during HUTT. Results: Twenty RLS patients reported a significant reduction of RLS symptoms after pramipexole treatment, while PSG did not show significant improvements except for periodic limb movement index. Pramipexole induced a trend to a lower systolic blood pressure and a significant higher variation of systolic and diastolic blood pressure at HUTT. Cardiovascular responses to the other tests were unchanged. No significant differences in HRV spectral analysis between drug naive and treated patients were observed. Moreover, the within-group analysis of HRV between orthostatic and supine position did not show any significant change in sympathetic and parasympathetic components both in the drug naive and pramipexole groups. Conclusions: Chronic pramipexole treatment does not seem to affect autonomic balance during wakefulness. Considering that neither PSG data nor autonomic parameters are significantly modified by pramipexole, we hypothesize a non-dopaminergic autonomic dysfunction in RLS.

AB - Objective: The link between the autonomic nervous system and restless legs syndrome (RLS) has been recently postulated. Since dopaminergic agents are used as first-line treatment for RLS, the purpose of our study is to verify whether chronic pramipexole treatment could influence the autonomic control of cardiovascular reflexes and heart rate variability (HRV) in RLS during wakefulness. Methods: Consecutive drug naive RLS patients underwent polysomnography (PSG), subjective scales, and cardiovascular function tests including head-up tilt test (HUTT), Valsalva maneuver, deep breathing, handgrip and cold face before and after 3-month pramipexole therapy. HRV analysis was performed in the frequency domain using both autoregressive and fast Fourier transform algorithms in rest supine condition and during HUTT. Results: Twenty RLS patients reported a significant reduction of RLS symptoms after pramipexole treatment, while PSG did not show significant improvements except for periodic limb movement index. Pramipexole induced a trend to a lower systolic blood pressure and a significant higher variation of systolic and diastolic blood pressure at HUTT. Cardiovascular responses to the other tests were unchanged. No significant differences in HRV spectral analysis between drug naive and treated patients were observed. Moreover, the within-group analysis of HRV between orthostatic and supine position did not show any significant change in sympathetic and parasympathetic components both in the drug naive and pramipexole groups. Conclusions: Chronic pramipexole treatment does not seem to affect autonomic balance during wakefulness. Considering that neither PSG data nor autonomic parameters are significantly modified by pramipexole, we hypothesize a non-dopaminergic autonomic dysfunction in RLS.

KW - Autonomic nervous system

KW - Cardiovascular reflexes

KW - Heart rate variability

KW - Pramipexole

KW - Restless legs syndrome

KW - Sleep

UR - http://www.scopus.com/inward/record.url?scp=84939511529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939511529&partnerID=8YFLogxK

U2 - 10.1016/j.sleep.2015.04.016

DO - 10.1016/j.sleep.2015.04.016

M3 - Article

C2 - 26298781

AN - SCOPUS:84939511529

VL - 16

SP - 1071

EP - 1076

JO - Sleep Medicine

JF - Sleep Medicine

SN - 1389-9457

IS - 9

ER -